AMAM News and Press, Ambrx Biopharma Inc. American Depositary Shares (each representing seven) From 05/30/23

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that Daniel J. O’Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview at the TD Cowen Oncology Innovation Summit,...

2023-05-24 08:49:06 ET Ambrx Biopharma ( NASDAQ: AMAM ) is set to sell ~5.4M American Depositary Shares at $13.93 per ADS in an ~$75M registered direct offering. The biopharmaceutical company has entered into a securities purchase agreement with clients managed by Darwin Globa...

SAN DIEGO, May 24, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that it has entered into a securities purchase agreement with clients managed by Darwin Global Management Ltd. (“Darwin”) for the sale of an ag...

2023-05-20 00:46:08 ET Summary Ambrx Biopharma's stock value has surged due to positive preliminary data from cancer-targeting clinical trials of ARX788 and ARX517. With cash reserves increasing to $149.6 million in Q1 2023, Ambrx can continue developing its innovative cancer trea...

2023-05-18 17:42:00 ET Shares of Ambrx Biopharma (NYSE: AMAM) were up 18.8% for the week after climbing as high as 25.4% for the week, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech stock closed at $11.64 last week, then rose to...

2023-05-18 16:26:36 ET Ambrx Biopharma ( NASDAQ: AMAM ) on Thursday said it had appointed Stephen Glover as chairman of its board of directors. The company's former chair, Katrin Rupalla, has resigned from the board to pursue another opportunity, AMAM said in a statement ....

SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Stephen Glover has joined the Company’s Board of Directors as Chairman. Mr. Glover has extensive experience building successful biopharmaceutical companies, with a focus on pharm...

2023-05-17 12:27:48 ET Summary Ambrx Biopharma Inc. is up 40x since February after posting positive clinical data. However, that sort of rally makes a stock unstable. I will watch Ambrx Biopharma Inc. from the sidelines. Ambrx Biopharma Inc. ( AMAM ) uses an ...

2023-05-17 08:29:00 ET Smart for Life ( SMFL ) +37% . Sunrise New Energy  ( EPOW ) +32% FY earnings call release Eightco Holdings  ( OCTO ) +22% Signs Inventory Management Agreement with Prominent Electronics Distributo GD Culture Group&#x...

SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Daniel J. O’Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview at the JMP Securities Life Sciences Conference and RBC Capital Markets Globa...